Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes …
IH de Boer, K Khunti, T Sadusky, KR Tuttle… - Diabetes …, 2022 - Am Diabetes Assoc
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure,
atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent …
atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent …
[HTML][HTML] A comprehensive review of cardiovascular disease management: cardiac biomarkers, imaging modalities, pharmacotherapy, surgical interventions, and …
VR Netala, SK Teertam, H Li, Z Zhang - Cells, 2024 - mdpi.com
Cardiovascular diseases (CVDs) continue to be a major global health concern, representing
a leading cause of morbidity and mortality. This review provides a comprehensive …
a leading cause of morbidity and mortality. This review provides a comprehensive …
ACE-Inhibitors in Hypertension: A historical perspective and current insights
Abstract Purpose of Review This review describes the discovery and development of ACE
inhibitors as antihypertensive agents, compares their efficacy, tolerability, and safety to …
inhibitors as antihypertensive agents, compares their efficacy, tolerability, and safety to …
Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations
Hypertension represents a major common cardiovascular risk factor. Optimal control of high
blood pressure levels is recommended to reduce the global burden of hypertensive …
blood pressure levels is recommended to reduce the global burden of hypertensive …
[HTML][HTML] The renin angiotensin system as a therapeutic target in traumatic brain injury
Traumatic brain injury (TBI) is a major public health problem, with limited pharmacological
options available beyond symptomatic relief. The renin angiotensin system (RAS) is …
options available beyond symptomatic relief. The renin angiotensin system (RAS) is …
[HTML][HTML] Secondary ischemic stroke prevention
The health burden of ischemic stroke is high and will continue to increase with an aging
population. Recurrent ischemic stroke is increasingly recognized as a major public health …
population. Recurrent ischemic stroke is increasingly recognized as a major public health …
Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid …
Aims The metabolic failure of macrophages to adequately process lipid is central to the
aetiology of atherosclerosis. Here, we examine the role of macrophage angiotensin …
aetiology of atherosclerosis. Here, we examine the role of macrophage angiotensin …
Angiotensin receptor blockers and cognition: a sco** review
Abstract Purpose of Review To provide an overview of the association between angiotensin
II receptor blocker (ARB) use and cognitive outcomes. Recent Findings ARBs have …
II receptor blocker (ARB) use and cognitive outcomes. Recent Findings ARBs have …
Valorization of chicken slaughterhouse byproducts to obtain antihypertensive peptides
Hypertension (HTN) is the leading cause of premature deaths worldwide and the main
preventable risk factor for cardiovascular diseases. Therefore, there is a current need for …
preventable risk factor for cardiovascular diseases. Therefore, there is a current need for …
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes
J Pawlonka, B Buchalska, K Buczma, H Borzuta… - … Treatment Options in …, 2024 - Springer
Opinion statement The renin–angiotensin–aldosterone system (RAAS) is a crucial regulator
of the cardiovascular system and a target for widely used therapeutic drugs. Dysregulation of …
of the cardiovascular system and a target for widely used therapeutic drugs. Dysregulation of …